• Home
  • Cilta-cel, a BCMA-targeting CAR-T therapy for heavily pretreated patients with relapsed/refractory multiple myeloma.

Cilta-cel, a BCMA-targeting CAR-T therapy for heavily pretreated patients with relapsed/refractory multiple myeloma.

Author List
Martin TG, Madduri D, Pacaud L, Usmani SZ
Publication
Future oncology (London, England)
Publication ID (Profile URL)
https://researcherprofiles.org/profile/415182413
Publication Year
2023
PubMed ID
37497629
Publication Title
Martin TG, Madduri D, Pacaud L, Usmani SZ. Cilta-cel, a BCMA-targeting CAR-T therapy for heavily pretreated patients with relapsed/refractory multiple myeloma. Future Oncol. 2023 Nov; 19(34):2297-2311.